Patents by Inventor Gerhard Hannig

Gerhard Hannig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120329720
    Abstract: The present invention provides anti-inflammatory compounds, pharmaceutical compositions thereof, and methods of use thereof for treating inflammatory disorders. The present invention also provides methods of identifying anti-inflammatory compounds and methods of inhibiting NF-?B-dependent target gene expression in a cell.
    Type: Application
    Filed: June 29, 2012
    Publication date: December 27, 2012
    Applicant: YALE UNIVERSITY
    Inventors: Michael J. May, Sankar Ghosh, Mark A. Findeis, Kathryn Phillips, Gerhard Hannig
  • Patent number: 8242240
    Abstract: The present invention provides anti-inflammatory compounds, pharmaceutical compositions thereof, and methods of use thereof for treating inflammatory disorders. The present invention also provides methods of identifying anti-inflammatory compounds and methods of inhibiting NF-?B-dependent target gene expression in a cell.
    Type: Grant
    Filed: August 27, 2010
    Date of Patent: August 14, 2012
    Assignee: Yale University
    Inventors: Michael J. May, Sankar Ghosh, Mark A. Findeis, Kathryn Phillips, Gerhard Hannig
  • Publication number: 20110071092
    Abstract: The present invention provides anti-inflammatory compounds, pharmaceutical compositions thereof, and methods of use thereof for treating inflammatory disorders. The present invention also provides methods of identifying anti-inflammatory compounds and methods of inhibiting NF-?B-dependent target gene expression in a cell.
    Type: Application
    Filed: August 27, 2010
    Publication date: March 24, 2011
    Applicant: YALE UNIVERSITY
    Inventors: Michael J. May, Sankar Ghosh, Mark A. Findeis, Kathryn Phillips, Gerhard Hannig
  • Patent number: 7812118
    Abstract: The present invention provides anti-inflammatory compounds, pharmaceutical compositions thereof, and methods of use thereof for treating inflammatory disorders. The present invention also provides methods of identifying anti-inflammatory compounds and methods of inhibiting NF-?B-dependent target gene expression in a cell.
    Type: Grant
    Filed: April 9, 2009
    Date of Patent: October 12, 2010
    Assignee: Yale University
    Inventors: Michael J. May, Sankar Ghosh, Mark A. Findeis, Kathryn Phillips, Gerhard Hannig
  • Publication number: 20090286748
    Abstract: The present invention provides anti-inflammatory compounds, pharmaceutical compositions thereof, and methods of use thereof for treating inflammatory disorders. The present invention also provides methods of identifying anti-inflammatory compounds and methods of inhibiting NF-?B-dependent target gene expression in a cell.
    Type: Application
    Filed: April 9, 2009
    Publication date: November 19, 2009
    Applicant: Yale University
    Inventors: Michael J. May, Sankar Ghosh, Mark A. Findeis, Kathryn Phillips, Gerhard Hannig
  • Patent number: 7534858
    Abstract: The present invention provides anti-inflammatory compounds, pharmaceutical compositions thereof, and methods of use thereof for treating inflammatory disorders. The present invention also provides methods of identifying anti-inflammatory compounds and methods of inhibiting NF-?B-dependent target gene expression in a cell.
    Type: Grant
    Filed: May 22, 2006
    Date of Patent: May 19, 2009
    Assignee: Yale University
    Inventors: Michael J. May, Sankar Ghosh, Mark A. Findeis, Kathryn Phillips, Gerhard Hannig
  • Publication number: 20070254303
    Abstract: The invention relates to methods for assessing the efficacy of treatment with a glucocorticoid by determining the amount of MetAP-2.
    Type: Application
    Filed: April 18, 2007
    Publication date: November 1, 2007
    Applicant: Praecis Pharmaceuticals Incorporated
    Inventors: Gerhard Hannig, William Westlin
  • Publication number: 20070254843
    Abstract: The instant invention provides methods and compositions for treating a subject suffering from bone associated diseases, such as osteoporosis.
    Type: Application
    Filed: April 18, 2007
    Publication date: November 1, 2007
    Applicant: Praecis Pharmaceuticals Incorporated
    Inventors: Gerhard Hannig, William Westlin
  • Publication number: 20060293244
    Abstract: The present invention provides anti-inflammatory compounds, pharmaceutical compositions thereof, and methods of use thereof for treating inflammatory disorders. The present invention also provides methods of identifying anti-inflammatory compounds and methods of inhibiting NF-?B-dependent target gene expression in a cell.
    Type: Application
    Filed: May 22, 2006
    Publication date: December 28, 2006
    Applicant: YALE UNIVERSITY
    Inventors: Michael May, Sankar Ghosh, Mark Findeis, Kathryn Phillips, Gerhard Hannig
  • Patent number: 7049395
    Abstract: The present invention provides anti-inflammatory compounds, pharmaceutical compositions thereof, and methods of use thereof for treating inflammatory disorders. The present invention also provides methods of identifying anti-inflammatory compounds and methods of inhibiting NF-?B-dependent target gene expression in a cell.
    Type: Grant
    Filed: May 2, 2001
    Date of Patent: May 23, 2006
    Assignee: Yale University
    Inventors: Michael J. May, Sankar Ghosh, Mark A. Findeis, Kathryn Phillips, Gerhard Hannig
  • Publication number: 20030083262
    Abstract: The present invention provides methods and compositions for treating inflammatory disorders, e.g., asthma, lung inflammation or cancer.
    Type: Application
    Filed: August 27, 2002
    Publication date: May 1, 2003
    Applicant: Praecis Pharmaceuticals Inc.
    Inventors: Gerhard Hannig, Douglas Lazarus
  • Publication number: 20030054999
    Abstract: The present invention provides anti-inflammatory compounds, pharmaceutical compositions thereof, and methods of use thereof for treating inflammatory disorders. The present invention also provides methods of identifying anti-inflammatory compounds and methods of inhibiting NF-&kgr;B-dependent target gene expression in a cell.
    Type: Application
    Filed: May 2, 2001
    Publication date: March 20, 2003
    Inventors: Michael J. May, Sankar Ghosh, Mark A. Findeis, Kathryn Phillips, Gerhard Hannig